Ruling Against Johnson & Johnson Unit Affirmed
In the latest development in a long-running battle over the multi-billion dollar market for drug-coated coronary stents, a federal judge in Delaware has affirmed a jury's decision that a stent made...To view the full article, register now.
Already a subscriber? Click here to view full article